Southeast BIOWhere Innovation Meets Opportunity

Jennifer H. Moore, Ph.D.Executive Director

Southeast Region Technology Transfer Directors Meeting

July 30, 2010

• Home to more than 1,200 life science companies

• World headquarters of major pharma/biotech companies

• Manufacturing facilities for several pharma/biotech companies

• World class research universities and institutions

• NC is home to one of the world's greatest concentration of CROs

• FL, GA and NC are ranked among the top US biotech centers

• Regional industry support groups have emerged

• State BIO groups and economic development agencies are active in cultivating the industry

Southeast Biotechnology Industry

Southeast BIO: A Regional Biotech Organization

• Founded in 1999 as a volunteer organization• Connect life science start-up companies with key players active in the region• Large BOD with broad regional and sector diversity• 13 VCs on the BOD, increases to 15 in 2011*

Accuitive Medical Ventures, Aurora Funds, Canaan Partners*, Domain Associates, Georgia Venture Partners, Harbert Venture Partners, Hatteras Venture Partners, H.I.G. Ventures, Intersouth Partners, Lilly Ventures*, MB Venture Partners, NEA*, Pappas Ventures, Quaker BioVentures, Tall Oaks Capital

Southeast BIO is a regional non-profit organization that fosters the growth of the life sciences industry in the Southeastern United States by

promoting entrepreneurship and bringing together the key stakeholders active in the development of the industry.

Host Annual Investor Forum:• allows companies to broadcast investment opportunity to

a targeted group of investors• provides companies with face-to-face feedback from

industry experts, including investors

Outcome:• showcased nearly 350 companies to investors in SE and

across the country• participating companies have raised over $2.5 billion in

private and public funding • investment in SE biotech companies has nearly tripled

since 1999

Southeast BIO: The Investor Forum

Southeast BIO: MAIN/Stage

Company Profile:• Completed one or more investment rounds attributable to

qualified venture capital firms • Active, credible management team • Advanced in the development cycle for their technology or

product opportunity

Program:• Application period open during summer preceding

conference• Selected companies allotted 10 minutes to present to full

conference audience • Alternating company presentations with panel discussions

featuring Southeast company success stories

Company Profile: • No prior institutional funding (Seed or ‘A’ Round)• Less developed management team; may be a scientific founder• May or may not have license agreement(s) in place

Program:• Application period open during summer preceding conference• 16 companies selected as semifinalists• Semifinalists have option to participate in a web-based consultation

session before the conference • Onsite, semifinalists present their opportunity to an advisory panel

during a 1 hour interactive, closed session• 4 finalists present to the full conference audience at the EARLY/Stage

Shootout • Finalists are awarded private meetings with investors in the region• Winner announced at the Investor Forum

Southeast BIO: EARLY/Stage

SEBIO: IDEA/Stage

Ideal Candidate: • Unincorporated opportunity with start-up potential• Supported by principals who:

• understand the technology and related IP• can articulate the commercial opportunity • are committed to taking the opportunity forward• are willing to be mentored  

• May have received some funding from typical pre- seed sources but no funding from institutional investors

SEBIO: IDEA/Stage

Program: • Application period open during spring preceding

conference• 10 semifinalists selected and paired with a mentoring team • Mentoring lasts 4-6 months • Goal is to develop the concept and write a development plan • Development plan submitted for judging• 4 finalists present their opportunity to the full conference

audience• Finalists are awarded private meetings with investors in the

region• Winner announced at the Investor Forum

SEBIO: Corporate Partnering Day

• Introduced to draw VCs/investors, particularly from outside the region• BD executives from major biotech/medical device companies will present partnering needs• 1-on-1 partnering meetings following presentations and throughout conference

Regional Information and Data Source: • For investors and entrepreneurs within and outside the

region who are looking at the Southeast for their next opportunity

Enhance Regional Awareness: • Among national VC firms and other investors

SEBIO: Future Directions

Primary Objective: Increase venture investment and deal flow in the region.

Create a Cohesive Regional Life Sciences Community: • To help attract and retain qualified entrepreneurs

and management teams

Enhance Mentoring Programs: • To continue to connect emerging companies with

key players in the region

SEBIO: Future Directions

November 3-4, 2010The Ritz-Carlton Buckhead

Atlanta, Georgia

Thank You!Jennifer Moore

Executive Director(Tel) 404-606-6246

(Email) jennifer@sebio.orgwww.sebio.org